Nov 30, 2020 / 02:00PM GMT
Operator
Good morning. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen and Sage collaboration investor call. (Operator Instructions) Thank you.
I would now like to turn the conference over to Mr. Joe Mara, Vice President, Investor Relations. Mr. Mara, you may now begin your conference.
Joe Mara - Biogen Inc. - VP of Finance & Head of IR
Thank you, and welcome to today's investor call to discuss our proposed collaboration between Biogen and Sage Therapeutics.
Before we begin, I encourage everyone to go to the Investors section of biogen.com to find the slides for today as well as the press release from last Friday, November 27, which includes additional details related to Biogen and Sage's global collaboration. I also want to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to
Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot